A Japanese, Multicenter, Open-label, Phase 3 Study to Investigate the Safety and Efficacy of Gadobutrol for Contrast-enhanced MR Imaging of the Central Nervous System-Reference-Cited by-同舟云学术

A Japanese, Multicenter, Open-label, Phase 3 Study to Investigate the Safety and Efficacy of Gadobutrol for Contrast-enhanced MR Imaging of the Central Nervous System

Published:2016 Issue:2 Volume:15 Page:227-236
ISSN:1347-3182
Container-title:Magnetic Resonance in Medical Sciences
language:en
Short-container-title:magn reson med sci

Author:

TANAKA Akio¹,MASUMOTO Tomohiko²,YAMADA Haruyasu³,KURAUCHI Masayo⁴,BREUER Josy⁵

Affiliation:

1. Department of Radiology, Ota Memorial Hospital

2. Department of Radiology, University of Tsukuba

3. Department of Radiology, Nihon University School of Medicine

4. Clinical Development Specialty Medicine, Bayer Yakuhin

5. Global Medical and Clinical Affairs Radiology, Bayer Pharma AG

Publisher

Japanese Society for Magnetic Resonance in Medicine

Subject

Radiology Nuclear Medicine and imaging

Link

https://www.jstage.jst.go.jp/article/mrms/15/2/15_mp.2015-0083/_pdf

Reference19 articles.

1. 1. Runge VM, Muroff LR, Jinkins JR. Central nervous system: review of clinical use of contrast media. Top Magn Reson Imaging 2001; 12:231–263.

2. 2. Runge VM, Muroff LR, Wells JW. Principles of contrast enhancement in the evaluation of brain diseases: an overview. J Magn Reson Imaging 1997; 7:5–13.

3. 3. Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 2005; 40:715–724.

4. 4. Attenberger UI, Runge VM, Jackson CB, et al. Comparative evaluation of lesion enhancement using 1 M gadobutrol vs. 2 conventional gadolinium chelates, all at a dose of 0.1 mmol/kg, in a rat brain tumor model at 3 T. Invest Radiol 2009; 44:251–256.

5. 5. Hammerstingl R, Adam G, Ayuso JR, et al. Comparison of 1.0 M gadobutrol and 0.5 M gadopentetate dimeglumine-enhanced magnetic resonance imaging in five hundred seventy-two patients with known or suspected liver lesions: results of a multicenter, double-blind, interindividual, randomized clinical phase-III trial. Invest Radiol 2009; 44:168–176.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Efficacy of Gadobutrol: Review of Over 25 Years of Use Exceeding 100 Million Administrations;Investigative Radiology;2023-10-18

2. Important Tools for Use by Pediatric Endocrinologists in the Assessment of Short Stature;Journal of Clinical Research in Pediatric Endocrinology;2021-06-01

3. Toxicity associated with gadolinium-based contrast-enhanced examinations;AIMS Biophysics;2021

4. Gadobutrol: A Review in Contrast-Enhanced MRI and MRA;Clinical Drug Investigation;2018-07-13